Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Neuroprotection by dimethyloxalylglycine following permanent and transient focal cerebral ischemia in rats

Nagel, Simon, Papadakis, Michalis, Chen, Ruoli, Hoyte, Lisa C, Brooks, Keith J, Gallichan, Daniel ORCID: https://orcid.org/0000-0002-0143-2855, Sibson, Nicola R, Pugh, Chris and Buchan, Alastair M 2011. Neuroprotection by dimethyloxalylglycine following permanent and transient focal cerebral ischemia in rats. Journal of Cerebral Blood Flow & Metabolism 31 (1) , pp. 132-143. 10.1038/jcbfm.2010.60

Full text not available from this repository.

Abstract

Dimethyloxalylglycine (DMOG) is an inhibitor of prolyl-4-hydroxylase domain (PHD) enzymes that regulate the stability of hypoxia-inducible factor (HIF). We investigated the effect of DMOG on the outcome after permanent and transient middle cerebral artery occlusion (p/tMCAO) in the rat. Before and after pMCAO, rats were treated with 40 mg/kg, 200 mg/kg DMOG, or vehicle, and with 40 mg/kg or vehicle after tMCAO. Serial magnetic resonance imaging (MRI) was performed to assess infarct evolution and regional cerebral blood flow (rCBF). Both doses significantly reduced infarct volumes, but only 40 mg/kg improved the behavior after 24 hours of pMCAO. Animals receiving 40 mg/kg were more likely to maintain rCBF values above 30% from the contralateral hemisphere within 24 hours of pMCAO. DMOG after tMCAO significantly reduced the infarct volumes and improved behavior at 24 hours and 8 days and also improved the rCBF after 24 hours. A consistent and significant upregulation of both mRNA and protein levels of vascular endothelial growth factor (VEGF) and endothelial nitric oxide synthase (eNOS) was associated with the observed neuroprotection, although this was not consistently related to HIF-1α levels at 24 hours and 8 days. Thus, DMOG afforded neuroprotection both at 24 hours after pMCAO and at 24 hours and 8 days after tMCAO. This effect was associated with an increase of VEGF and eNOS and was mediated by improved rCBF after DMOG treatment.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Cardiff University Brain Research Imaging Centre (CUBRIC)
Engineering
Subjects: T Technology > TA Engineering (General). Civil engineering (General)
Uncontrolled Keywords: cerebral blood flow, dimethyloxalylglycine, hypoxia-inducible factor, middle cerebral artery occlusion, MRI, neuroprotection prolyl-hydroxylases
Publisher: SAGE Publications
ISSN: 0271-678X
Last Modified: 02 Nov 2022 10:22
URI: https://orca.cardiff.ac.uk/id/eprint/98396

Citation Data

Cited 88 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item